In recent years, the anti-PD-1/PD-L1 blockade has become a game changer in cancer
treatment following the unprecedented response rate. Regardless of the substantial therapy …

The increasing number of cancer-associated deaths despite the substantial improvement in
diagnosis and treatment has sparked discussions on the need for novel biomarkers and …

Focal adhesion kinase (FAK) expression has been linked to tumor growth,
immunosuppression, metastasis, angiogenesis, and therapeutic resistance through kinase …

The continuous increase in cancer-associated deaths despite the substantial improvement
in diagnosis and treatment has sparked discussions on the need for novel biomarkers and …

The neutrophils exhibit both anti-tumor and pro-tumor effects in cancers. The correlation
between neutrophils and tumor development in lung adenocarcinoma (LUAD) is still …

Immune cells infiltrating the tumor microenvironment are physiologically important in
controlling cancers. However, emerging studies have shown that cancer cells can evade …

The immune component of the tumor microenvironment is essential for the regulation of
cancer progression. In breast cancer (BC), a patient's tumor mass is frequently infiltrated by …

Cancer immunotherapy, particularly immune checkpoint inhibitors, has opened a new
avenue for cancer treatment following the durable clinical benefits. Despite the clinical …

Non-small cell lung carcinoma (NSCLC) accounts for 85% of lung cancers, the leading
cause of cancer associated deaths in the US and worldwide. Within NSCLC tumors, there is …

Simple Summary Cutaneous T cell lymphomas (CTCLs) are a group of rare
lymphoproliferative malignancies manifesting in the skin. Cutaneous T cell lymphomas are …